ATE472334T1 - Polypeptidsequenzen, die an der modulation des immunsupppressiven effekts viraler proteine beteiligt sind - Google Patents

Polypeptidsequenzen, die an der modulation des immunsupppressiven effekts viraler proteine beteiligt sind

Info

Publication number
ATE472334T1
ATE472334T1 AT05716455T AT05716455T ATE472334T1 AT E472334 T1 ATE472334 T1 AT E472334T1 AT 05716455 T AT05716455 T AT 05716455T AT 05716455 T AT05716455 T AT 05716455T AT E472334 T1 ATE472334 T1 AT E472334T1
Authority
AT
Austria
Prior art keywords
modulating
polypeptide sequences
viral proteins
sequences involved
immunosuppressive effect
Prior art date
Application number
AT05716455T
Other languages
English (en)
Inventor
Martial Renard
Marianne Mangeney
Thierry Heidmann
Original Assignee
Roussy Inst Gustave
Centre Nat Rech Scient
Univ Paris Sud Xi
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roussy Inst Gustave, Centre Nat Rech Scient, Univ Paris Sud Xi filed Critical Roussy Inst Gustave
Application granted granted Critical
Publication of ATE472334T1 publication Critical patent/ATE472334T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pulmonology (AREA)
  • Transplantation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT05716455T 2004-03-30 2005-03-30 Polypeptidsequenzen, die an der modulation des immunsupppressiven effekts viraler proteine beteiligt sind ATE472334T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP04290838 2004-03-30
PCT/EP2005/003339 WO2005095442A1 (en) 2004-03-30 2005-03-30 Polypeptide sequence involved in the modulation of the immunosuppresive effect of viral proteins

Publications (1)

Publication Number Publication Date
ATE472334T1 true ATE472334T1 (de) 2010-07-15

Family

ID=34896141

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05716455T ATE472334T1 (de) 2004-03-30 2005-03-30 Polypeptidsequenzen, die an der modulation des immunsupppressiven effekts viraler proteine beteiligt sind

Country Status (14)

Country Link
US (2) US8178657B2 (de)
EP (1) EP1732585B1 (de)
JP (1) JP5060284B2 (de)
CN (1) CN1961001B (de)
AT (1) ATE472334T1 (de)
AU (1) AU2005229411B2 (de)
BR (1) BRPI0509497B1 (de)
CA (1) CA2561376C (de)
DE (1) DE602005022056D1 (de)
ES (1) ES2347445T3 (de)
IL (1) IL178205A (de)
MX (1) MXPA06011272A (de)
WO (1) WO2005095442A1 (de)
ZA (1) ZA200608178B (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9777044B2 (en) 2003-05-02 2017-10-03 Centre National De La Recherche Scientifique (Cnrs) GLUT-1 as a receptor for HTLV envelopes and its uses
WO2006103562A2 (en) 2005-03-30 2006-10-05 Centre National De La Recherche Scientifique (Cnrs) Endogenous retrovirus and proteins encoded by env gene as a target for cancer treatment
US20070185025A1 (en) * 2005-09-11 2007-08-09 The Trustees Of Columbia University In The City Of New York Filoviral immunosuppressive peptides and uses thereof
US20080299150A1 (en) * 2007-05-08 2008-12-04 Sankhia Corporation Method and system for processing immuno-competent cells in view of an antiviral therapy, and related therapeutic process
US8323891B2 (en) * 2008-08-01 2012-12-04 Claflin University miRNA triplex formations for the downregulation of viral replication
RU2008140688A (ru) * 2008-10-15 2010-04-20 Михаил Аркадьевич Шурдов (RU) Иммуносупрессивный пептид
EP2376917B1 (de) 2009-01-09 2016-03-30 Centre National De La Recherche Scientifique Neue rezeptorbindende liganden und ihre verwendung für den nachweis von zellen von biologischem interesse
WO2011092199A1 (en) * 2010-01-26 2011-08-04 Institut Gustave Roussy Mutated xmrv env proteins in the immunosuppressive domain
US20130197612A1 (en) 2010-02-26 2013-08-01 Jack W. Lasersohn Electromagnetic Radiation Therapy
US20130260394A1 (en) * 2010-09-17 2013-10-03 Centre National De La Recherche Scientifique Method for the diagnosis and/or prognosis of inflammatory states
EP2734230B1 (de) * 2011-07-20 2018-11-21 Merial Limited Rekombinante katzenleukämievirusvakzine die ein optimiertes gen des hüllproteins des katzenleukämievirus enthält
KR102059918B1 (ko) * 2011-12-07 2020-02-11 비록시스 에스.아.에스. 돌연변이형 렌티바이러스 env 단백질 및 이의 약물로서의 용도
US9636396B2 (en) 2011-12-07 2017-05-02 Centre National De La Recherche Scientifique Mutant human and simian immunodeficiency virus ENV proteins with reduced immunosuppressive properties
US9974852B2 (en) 2013-06-07 2018-05-22 Viroxis Sas Mutated non-primate lentiviral Env proteins and their use as drugs
WO2016199674A1 (ja) * 2015-06-11 2016-12-15 学校法人慶應義塾 融合タンパク質又は複合タンパク質、細胞内送達用担体、部分ペプチド、細胞膜透過促進剤、ｄｎａ、及びベクター
EP3356389A1 (de) * 2015-10-01 2018-08-08 Aimvion A/S Verwendung von menschlichen immunsuppressiven proteinen und peptiden als arzneimittel
EP4450516A3 (de) * 2017-09-01 2025-01-22 InProTher ApS Impfstoff zur verwendung bei der prophylaxe und/oder behandlung einer erkrankung
EP3852813A4 (de) 2018-09-18 2022-06-22 VNV Newco Inc. Lichtbogenbasierte kapside und deren verwendungen
US11129892B1 (en) 2020-05-18 2021-09-28 Vnv Newco Inc. Vaccine compositions comprising endogenous Gag polypeptides
US20240093233A1 (en) 2021-01-13 2024-03-21 Viroxis Measles-hiv or measles-htlv vaccine
CN121752289A (zh) 2023-04-21 2026-03-27 盈珀治疗有限公司 表面展示抗原的改善表达

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4822606A (en) * 1986-04-07 1989-04-18 Duke University Immunosuppressive synthetic peptides and analogs thereof based on retroviral envelope sequences
ES2084596T3 (es) * 1988-12-13 1996-05-16 Harvard College Materiales aislados de felv prototipos para uso en modelos de enfermedades y vacunas.
FR2771011B1 (fr) * 1997-11-17 2000-01-28 Hippocampe Obtention de vaccins destines a prevenir les effets pathogenes associes a une infection retrovirale
FR2780069B1 (fr) * 1998-06-23 2002-06-28 Inst Nat Sante Rech Med Famille de sequences nucleiques et de sequences proteiques deduites presentant des motifs retroviraux endogenes humains et leurs applications
EP1224291A1 (de) * 1999-10-28 2002-07-24 Universite De Geneve Multiple sklerose superantigen
WO2002047720A2 (en) * 2000-12-11 2002-06-20 Tufts University Treatment and prevention of ebv infection and ebv-associated disorders
GB0112126D0 (en) 2001-05-18 2001-07-11 Allergene Inc Composition

Also Published As

Publication number Publication date
WO2005095442A1 (en) 2005-10-13
WO2005095442A8 (en) 2006-11-02
BRPI0509497B1 (pt) 2022-07-19
EP1732585B1 (de) 2010-06-30
DE602005022056D1 (de) 2010-08-12
MXPA06011272A (es) 2007-04-17
ZA200608178B (en) 2008-10-29
BRPI0509497A (pt) 2007-09-11
AU2005229411A1 (en) 2005-10-13
IL178205A (en) 2015-05-31
US8597657B2 (en) 2013-12-03
IL178205A0 (en) 2006-12-31
US8178657B2 (en) 2012-05-15
ES2347445T3 (es) 2010-10-29
CA2561376C (en) 2016-06-21
CN1961001A (zh) 2007-05-09
AU2005229411B2 (en) 2010-11-18
US20080008683A1 (en) 2008-01-10
JP5060284B2 (ja) 2012-10-31
CN1961001B (zh) 2012-09-05
JP2008506357A (ja) 2008-03-06
US20120189647A1 (en) 2012-07-26
CA2561376A1 (en) 2005-10-13
EP1732585A1 (de) 2006-12-20

Similar Documents

Publication Publication Date Title
ATE472334T1 (de) Polypeptidsequenzen, die an der modulation des immunsupppressiven effekts viraler proteine beteiligt sind
PT1685243E (pt) Linhas celulares aviárias imortalizadas para a produção de vírus
EA201892561A1 (ru) Гибридные белки gdf15 и их применение
EA201991168A1 (ru) Белок, связывающий простатический специфический мембранный антиген
PH12019500596B1 (en) Recombinant binding proteins and their use
PH12022552935A1 (en) Stabilized coronavirus spike protein fusion proteins
DE69942459D1 (de) Isolierte nukleinsäuremoleküle die t-zellen induzierbare faktoren kodieren (tif), kodierte proteine und ihre anwendung
MX2007007586A (es) Composiciones de proteinas de virus de gripe y metodos de uso de las mismas.
AR113492A2 (es) Furina recombinante libre de proteínas sustancialmente animal y métodos para producirla
SG10201903142RA (en) Serpin fusion polypeptides and methods of use thereof
JOP20240256A1 (ar) بروتينات اندماج hmpv مُستقرة في صورة ما قبل الإندماج
MX2021014649A (es) Dominio de repetición de anquirina diseñado con estabilidad mejorada.
MXPA05009743A (es) Composiciones con actividad hematopoyetica e inmune.
ATE542915T1 (de) Cst-ii-modifzierungen für erhöhte proteinexpression
IL173952A0 (en) Anti-angiogenic peptides and pharmaceutical compositions based thereon
ATE486128T1 (de) Zusammensetzungen und verfahren zur erhöhung der produktion rekombinanter gamma-carboxylierter proteine
PH12022553417A1 (en) Stabilized corona virus spike protein fusion proteins
DE60330680D1 (de) Transferrin-fusionsproteinbibliotheken
WO2006047728A3 (en) Bmp gene and fusion protein
GB2469395A (en) Methods and compounds for phototransfer
WO2006058159A3 (en) Methods and compositions for the ex vivo high-throughput detection of protein/protein interactions
KR20040053279A (ko) 스트레스 저항성 및 내성 단백질을 코딩하는 유전자
AR068038A1 (es) Polipeptidos de la hormona de crecimiento modificada
DK1594991T3 (da) Fremgangsmåde til fremstilling af DNA-molekyler
ATE450546T1 (de) Impfstoffe mit ornithobakterium rhinotracheale- untereinheit

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties